Et(cre/ERT2)4Rdav
Transgene Detail
|
Symbol: |
Et(cre/ERT2)4Rdav |
Name: |
enhancer trap 4, Ron Davis |
MGI ID: |
MGI:3852322 |
Transgene: |
Et(cre/ERT2)4Rdav Location: unknown
|
Alliance: |
Et(cre/ERT2)4Rdav page
|
|
Strain of Origin: |
C57BL/6J
|
Project Collection: |
Neuroscience Blueprint cre
|
|
Transgene Type: |
|
Transgenic (Inducible, Recombinase) |
Inducer: |
|
tamoxifen |
Mutation: |
|
Insertion
|
|
|
Mutation details: An enhancer trap transgenic approach was used to generate these mice. The TK-bgi-cre:ERT2-bGHpA transgene was designed with the thymidine kinase (TK) minimal promoter driving a cre-ERT2 fusion gene (cre recombinase fused to a G400V/M543A/L544A triple mutation of the human estrogen receptor ligand binding domain). A beta globin intron separates the promoter from the cre gene and the bovine growth hormone polyadenylation signal follows the cre sequence. This transgene was injected into C57BL/6J embryos. Founder line 4 was established on a C57BL/6J genetic background.
(J:150856)
|
|
|
Activity: |
 Tissue activity of this recombinase allele
|
Driver:
|
Et(cre/ERT2)4Rdav
(mouse)
|
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
Original: |
J:150856 Davis R, Large-scale enhancer trap project to generate transgenic cre alleles by Ron Davis at Baylor University. MGI Direct Data Submission. 2009; |
All: |
2 reference(s) |
|